BillionToOne CEO and leadership

David believes that applying engineering principles to biology will be transformative for medicine. He is the original inventor of the DNA molecular counting platform at BillionToOne and has presented BillionToOne’s clinical trial results at national medical conferences. David has a bachelor’s degree in Physics, cum laude, from Princeton University with minors in Biophysics and Engineering Management Systems. While at Princeton, he was twice awarded the Shenstone Prize in Physics. He received a PhD in bioengineering from Rice University, where he was awarded a Nanobiology training fellowship.

Strategic finance executive with 20 years of progressive experience in Tech industry and working at a big four accounting firm. Experience with Healthcare, Software, SaaS, Hardware and Consumer based business models. Skilled at building and scaling the Global Finance function for hyper growth Companies (supported revenue growth of over 100%+) Key Skills and Experience includes: - Long Range Planning, Budgeting & Forecasting (tracking KPI's)- Capital Raises: Equity and Debt Financing - Business Modelling and evaluation of various capital intensive projects- M&A and Divestitures - Due Diligence, Valuation & Integration aspects (involved in 40+ closed transactions spanning Software, SaaS, Hardware and Media companies aggregating over $25B) - Assisting with Investor Relations: data driven analysis to support the Company's story and investor presentations- Business partnering and working closely with Sales Operations, Corporate Development, Legal and HR functions on various cross-functional initiatives- Tax and Treasury Management- Complex Revenue Recognition models including ASC 606 implementation - Systems Implementations and Enhancements: Global cloud ERP implementation (Netsuite)- Building High Growth teams to support global footprint (setting international operations) - mentoring and coaching - Board Presentations and Reporting

David believes that applying engineering principles to biology will be transformative for medicine. He is the original inventor of the DNA molecular counting platform at BillionToOne and has presented BillionToOne’s clinical trial results at national medical conferences. David has a bachelor’s degree in Physics, cum laude, from Princeton University with minors in Biophysics and Engineering Management Systems. While at Princeton, he was twice awarded the Shenstone Prize in Physics. He received a PhD in bioengineering from Rice University, where he was awarded a Nanobiology training fellowship.